Article: PROXY CORNER: Biomet Inc.

Biomet Inc., 56 E. Bell Drive, Warsaw, 46582 (www.biomet.com) and its subsidiaries design, manufacture and market products used primarily by orthopedic medical specialists in both surgical and non-surgical therapy. For the year ended May 31, the company reported net income of $336 million, or $1.68 per diluted share, on $2.1 billion in revenue. Those totals compare with net income of $406 million, or $1.69 per diluted share, on $2.0 billion in revenue for the previous year. The company's shares trade on NASDAQ under the ticker symbol BMET. Information for Proxy Corner was taken from Bloomberg News and from the company's annual report statement dated July 30, 2007.

VALUE

(Table omitted)

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!